Dulaglutide biosimilar (Lepu pharma)

度拉糖肽生物类似药（乐普药业）

Report date: 2023/01/30 20:00:39

Base Information

Drug NameDulaglutide biosimilar (Lepu pharma)
Drug Alias NameRecombinant GLP-1 receptor agonists （Lepu pharma）重组GLP-1受体激动剂（乐普药业）
ClassificationBiologics > Protein drugs > Recombinant polypeptideBiologics > Biosimilar
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesBeijing Lepu Pharmaceutical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Lepu Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A